Pharmaceutical news monitoring, prioritized for your market.
Track the news most likely to affect your pipeline, competitors, and growth strategy. Filter by company, asset, disease area, pipeline change, clinical readout, and sentiment.
Outcome: less time filtering headlines and more time assessing the signals that matter.
See the signals behind the headlines
Clinical readouts
Track topline data, interim results, conference presentations, and study milestones.
Pipeline changes
Identify new programmes, phase advances, discontinuations, deprioritisations, and licensing activity.
Approvals and regulatory events
Follow FDA and other regulatory developments that can alter treatment landscapes and competitive timing.
Company events
Stay current on partnerships, acquisitions, financings, leadership changes, and strategic portfolio decisions.
Sentiment and context
Understand whether news signals positive momentum, emerging risk, or a potentially material competitive shift.
News connected to your intelligence workflow
Every signal is more useful with context. RxClarity connects news to the underlying company, drug, trial, indication, and competitive landscape so teams can move from headline to implication faster.